Longevity9 min read·Published August 10, 2026

Nicotinamide Adenine Dinucleotide Injection: Uses, Evidence, Safety, and Cost

What NAD+ injections are, how they differ from oral precursors and IV infusions, and what human research does and does not show.

Nicotinamide Adenine Dinucleotide Injection: Uses, Evidence, Safety, and Cost

Nicotinamide adenine dinucleotide, or NAD+, is a coenzyme your cells use for energy metabolism, DNA repair pathways, and cell signaling. NAD+ injections are compounded prescription treatments used in some longevity and wellness protocols, but they are not FDA-approved and human evidence is still limited. A licensed clinician should review eligibility, risks, and goals first.

Wondering if semaglutide is right for you? Take the 3-min clinical quiz.

See if you qualify →

What is nicotinamide adenine dinucleotide injection?

Nicotinamide adenine dinucleotide injection is a compounded prescription form of NAD+, a coenzyme found in cells throughout the body. NAD+ is not a hormone, stimulant, GLP-1 medication, or vitamin by itself; it is a molecule your cells use in many chemical reactions.

NAD+ is best known for its role in oxidative phosphorylation, the mitochondrial process that helps make ATP, the cell’s usable energy currency. It is also involved in DNA repair signaling, calcium-dependent signaling, and gene expression pathways 1.

What NAD+ does in the body

NAD+ acts like an electron shuttle. In the NAD+/NADH redox pair, NAD+ accepts electrons and becomes NADH; NADH then donates electrons into energy-making pathways in mitochondria. This back-and-forth chemistry helps cells turn food into usable energy 1.

NAD+ is also consumed by enzyme families such as sirtuins and PARPs. Sirtuins help regulate stress-response and metabolism signals, while PARPs help coordinate DNA repair after cell damage 2.

How NAD+ differs from NADH, NR, and NMN

NAD+ and NADH are two forms of the same redox pair. NAD+ is the oxidized form, and NADH is the reduced form. Nicotinamide riboside, or NR, and nicotinamide mononucleotide, or NMN, are NAD+ precursors, meaning the body can use them as building blocks to make NAD+ 3.

Niacin and tryptophan can also feed NAD+ production pathways 3. These routes are one reason oral NAD+ precursors are studied separately from injected or infused NAD+.

Why injections are used instead of oral NAD+

Oral supplements, nasal sprays, injections, and IV infusions may differ in absorption, convenience, tolerability, and cost. The main reason people consider injections is practical: they want a provider-guided route that bypasses part of the digestive process. But that does not mean injections have proven longevity benefits.

How do NAD+ injections work in the body?

NAD+ works by supporting cell chemistry rather than by turning one receptor on or off. It helps power energy reactions and serves as a substrate for enzymes that control repair and stress-response pathways.

NAD+ and mitochondrial energy production

Mitochondria use electron flow to help generate ATP. NADH donates electrons into this system, while NAD+ is regenerated so the cycle can continue. This is why NAD+ metabolism is often discussed in fatigue and energy research, though symptom improvement is not guaranteed 1.

NAD+ as a substrate for sirtuins and PARPs

Sirtuins and PARPs use NAD+ as part of their normal activity. When these enzymes use NAD+, they break it down as part of signaling reactions. This links NAD+ status to DNA repair, inflammation signaling, metabolism, and stress response in cell and animal models 2.

Why NAD+ metabolism is studied in aging research

Aging research focuses on NAD+ because NAD-related pathways affect mitochondrial function, DNA repair, immune signaling, and cellular stress response. Reviews support a biologic rationale for studying NAD+ pathways in aging, but they do not show that NAD+ injections extend human lifespan 2.

What does human research say about NAD+ injections?

Human evidence for NAD+ injections is still limited. Most better-controlled human research involves NADH or oral NAD+ precursors such as NR, not prescription compounded NAD+ injections.

What randomized trials and systematic reviews show for NADH and NAD+ precursors

A 2023 systematic review included 10 randomized clinical trials with 489 total participants across conditions such as chronic fatigue syndrome, Parkinson’s disease, older age, overweight, postmenopausal prediabetes, and Alzheimer’s disease. The review found NADH and NAD+ precursor supplementation was generally well tolerated, but it concluded that more research is needed before clear disease-specific or dosing conclusions can be made 1.

In a randomized trial of older adults, nicotinamide riboside raised blood NAD+ metabolites and was well tolerated, but the trial was small and focused mainly on safety and biomarker outcomes, not lifespan 4. In a randomized study of postmenopausal women with prediabetes, NMN increased muscle insulin sensitivity in the treatment group, but this does not prove that NAD+ injections improve weight or prevent disease 5.

What human evidence exists for IV NAD+

IV NAD+ has been formally studied in humans. For example, ClinicalTrials.gov lists NCT02942888, a study of intravenous nicotinamide adenine dinucleotide in a clinical research setting 6. A registered study shows scientific interest, but it does not prove broad wellness, energy, or longevity benefits.

A 2026 retrospective commercial-setting study compared four consecutive days of 500 mg IV NAD+ with IV nicotinamide riboside and followed participants for 30 days. NAD+ IV was linked with more moderate-to-severe gastrointestinal symptoms, higher heart rate, and chest pressure during infusion, while symptoms resolved after infusion completion 7.

In that same study, researchers reported no significant 30-day changes in ALT, AST, hsCRP, BUN/creatinine, or TSH after commercially administered IV NAD+ or IV NR. Exploratory metabolic findings were variable and need more study 7.

How to separate human, animal, and cell findings

  • Human randomized evidence: strongest for testing safety and specific outcomes, but most NAD studies are still small and often involve oral precursors rather than injections.
  • Human observational evidence: useful for real-world safety signals, but it cannot prove cause and effect.
  • Animal evidence: helpful for mechanisms and aging biology, but animal lifespan findings do not prove longer human life.
  • Cell evidence: useful for mapping pathways such as sirtuins, PARPs, and CD38, but cell results are not clinical outcomes.

3-min quiz

Considering NAD+ with clinician guidance?

Chia offers NAD+ injection and NAD+ nasal spray through a 100% online visit. A licensed US provider reviews your health history and prescribes only when clinically appropriate; a prescription is never guaranteed. Compounded drugs are not FDA-approved and have not been reviewed by FDA for safety, effectiveness, or quality before dispensing.

What are the possible benefits people seek from NAD+ injections?

People often look at NAD+ injections for energy, fatigue, metabolic health, and longevity goals. The science is plausible at the cell level, but proven clinical benefits are much narrower than many wellness claims suggest.

Energy and fatigue: what is plausible versus proven

Because NAD+ is tied to ATP production, it is biologically plausible that NAD-targeted therapies could affect fatigue in some settings. But the 2023 systematic review found mixed early evidence across different conditions and called for more rigorous research 1.

This is where expectations matter. NAD+ is not a stimulant, and an energy benefit is not guaranteed. Side effects such as headache, fatigue, muscle pain, nervous-system symptoms, and sleep disturbance were reported across included human trials, even though no serious health risk was reported in that review 1.

Metabolic health markers: what small studies suggest

Some NAD+ precursor studies suggest effects on metabolic markers. For example, a randomized trial of NMN in postmenopausal women with prediabetes reported increased muscle insulin sensitivity in the NMN group 5. That finding is interesting, but it does not mean NAD+ injections cause weight loss or replace evidence-based treatment for diabetes or obesity.

Longevity claims: why biomarkers do not prove longer human lifespan

A biomarker can move without changing how long people live. Current reviews support NAD+ as an important aging-research pathway, but they do not establish that NAD+ injections extend human lifespan 2. Individual results vary, and human longevity claims should be treated as investigational.

What are the downsides and side effects of NAD+ injections?

NAD+ side effects depend on the person, route, dose, and how fast a treatment is given. A clinician should review medical history, medications, and goals before treatment.

Commonly reported side effects in human studies

In the 2023 systematic review, reported adverse effects across included human trials included muscle pain, nervous-system symptoms, fatigue, sleep disturbance, and headaches. The review reported no serious health risk in the included studies, but the evidence base was small and varied 1.

In the 2026 retrospective IV study, NAD+ IV was associated with more gastrointestinal symptoms, increased heart rate, and chest pressure during infusion than IV NR. Symptoms resolved after the infusion ended, but this still matters for safety screening and route choice 7.

Why route and infusion speed may affect tolerability

IV infusion gives NAD+ directly into the bloodstream and may cause infusion-related symptoms in some people. Injections and nasal sprays are different routes, so IV tolerability data should not be treated as proof of the same effect for every form.

Who should talk with a clinician before considering NAD+

Anyone with heart symptoms, kidney or liver disease, pregnancy, breastfeeding, cancer history, complex medication use, or unexplained fatigue should talk with a licensed clinician before considering NAD+. These issues may change whether NAD+ is appropriate or whether other testing should come first.

Is NAD+ like Ozempic?

NAD+ is not Ozempic. NAD+ is a coenzyme involved in cell metabolism, while Ozempic is a brand name for semaglutide, a GLP-1 receptor agonist used for glycemic control in adults with type 2 diabetes 8.

NAD+ is a coenzyme, not a GLP-1 receptor agonist

GLP-1 receptor agonists work through hormone-like receptor signaling that affects insulin, glucagon, appetite, and gastric emptying. NAD+ does not work that way. It participates in redox chemistry and enzyme signaling inside cells.

How Ozempic and semaglutide work differently

Semaglutide is the active ingredient in Ozempic and other semaglutide products. FDA labeling for Ozempic describes semaglutide as a GLP-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, with other label-specific risk-reduction information 8.

When weight-loss treatment may be a separate conversation

If weight loss is the main goal, that is a separate medical conversation. Chia offers compounded semaglutide injection and compounded tirzepatide tablets or injection for eligible patients after licensed-provider review. Compounded GLP-1 medications are not FDA-approved, and outcomes data are not established for compounded formulations.

How much do NAD+ injections cost?

NAD+ injection cost varies by route, dose, pharmacy, provider model, and whether follow-up care is included. Prescription compounded NAD+ is usually priced differently from cash-pay wellness IV clinics.

Why prices vary by route, dose, pharmacy, and provider model

An IV clinic may charge per infusion, while a telehealth prescription model may include clinician review, pharmacy dispensing, and home delivery. The route also matters: IV infusion, injection, nasal spray, and oral precursors have different cost structures.

How prescription compounded NAD+ differs from wellness IV clinics

With prescription compounded NAD+, a licensed clinician reviews whether treatment is appropriate before prescribing. With walk-in wellness IV models, the medical review, monitoring, and continuity of care can vary by clinic.

What to ask before paying for NAD+ treatment

  • Who reviews my medical history before treatment?
  • Is the medication prepared by a state-licensed pharmacy?
  • What route is being used: injection, nasal spray, IV infusion, or oral precursor?
  • What follow-up is included if side effects occur?
  • Are longevity or energy claims being stated as proven when the human evidence is still limited?

How long should someone stay on NAD+ injections?

There is no one-size-fits-all duration for NAD+ injections. Duration should be based on clinician review, goals, tolerability, response, and whether treatment still makes sense over time.

Why there is no one-size-fits-all duration

NAD+ use for wellness, energy, and longevity goals is investigational. Because long-term injection-specific outcomes are not well established, ongoing use should not be treated as automatic.

How clinicians may reassess goals, tolerability, and labs over time

A clinician may reassess symptoms, side effects, medications, health changes, and selected labs over time. The right plan may be to continue, pause, change route, or look for another cause of symptoms such as fatigue.

When stopping or changing therapy should be discussed

New chest symptoms, rapid heart rate, allergic-type symptoms, severe nausea, worsening fatigue, or new medical diagnoses should prompt a clinician check-in. Stopping or changing therapy should be guided by the prescribing clinician.

NAD+ injections at Chia: online clinician review and home delivery

At Chia, NAD+ is available as injection and nasal spray for patients who complete an online health questionnaire and are approved by a licensed US provider. Plans currently start at $179/month for NAD+ injection and $119/month for NAD+ nasal spray; the NAD+ product page has current details.

Here is how treatment works: you complete a short online health questionnaire, our providers review your medical history, and medication is prescribed only where clinically appropriate. If prescribed, medication is compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door.

NAD+ also appears in Chia protocols where it fits a broader goal. Foundation Longevity includes Sermorelin Injection, NAD+ Injection, and Glutathione Injection. Glow includes GHK-Cu Cream, Glutathione Injection, and NAD+ Injection. Weight + Energy includes NAD+ Injection plus a choice of GLP-1 when clinically appropriate.

For patients using AI-agent prescription workflows, Chia can also be reached through DoctorMCP at mcp.chia.health when the workflow is clinically appropriate. The same rule applies: a licensed-provider evaluation is required, and a prescription is never guaranteed.

Chia NAD+ optionFormCurrent starting priceBest fit
NAD+InjectionFrom $179/moFor patients who prefer provider-guided injectable treatment at home
NAD+Nasal sprayFrom $119/moFor patients who prefer a non-injection route
Foundation LongevitySermorelin Injection + NAD+ Injection + Glutathione InjectionFrom $399/moFor a broader clinician-reviewed longevity protocol
GlowGHK-Cu Cream + Glutathione Injection + NAD+ InjectionFrom $349/moFor a skin and wellness-focused protocol
Weight + EnergyNAD+ Injection + choice of GLP-1From $309/moFor eligible patients discussing weight care and energy support together

How should patients compare NAD+ injection, nasal spray, IV infusion, and oral precursors?

The best route depends on evidence limits, convenience, tolerability, cost, and clinician oversight. No route has proven that it extends human lifespan.

RouteWhat it isTypical settingEvidence limitsPractical trade-off
Compounded NAD+ injectionPrescription NAD+ given by injectionHome use after clinician review when prescribedInjection-specific human outcome data are limitedConvenient for some patients, but requires comfort with injections
Compounded NAD+ nasal sprayPrescription NAD+ delivered intranasallyHome use after clinician review when prescribedHuman outcome data for this route are limitedNo needle, but absorption and response may vary
IV NAD+ infusionNAD+ infused into a veinClinic or IV settingSome human data exist, including observational tolerability data, but benefits remain unprovenClinic time, higher visit burden, and infusion-related symptoms may occur
Oral NR, NMN, niacin, or other precursorsBuilding blocks the body may use to make NAD+Supplement or study settingMore randomized human data exist for some precursors than for injections, but outcomes varyEasy to take, but product quality and absorption can vary

Questions to ask a licensed provider

  • What goal are we trying to measure: fatigue, recovery, metabolic markers, or general wellness?
  • What evidence supports this route for my goal?
  • What side effects should make me stop and contact the care team?
  • Do any of my medications or conditions change the risk-benefit picture?
  • How will we decide whether to continue, pause, or change the plan?

Red flags in NAD+ marketing claims

  • Claims that NAD+ injections are proven to reverse aging or extend human lifespan
  • Promises of guaranteed energy, weight loss, or brain benefits
  • No licensed clinician review before treatment
  • No clear pharmacy or sourcing information
  • Pressure to buy long packages before safety and goals are reviewed

3-min quiz

Start with an online clinical review

If you are considering NAD+ for a wellness or longevity protocol, Chia can help you review options through an online visit. Our providers prescribe only when clinically appropriate, and compounded medications are dispensed through state-licensed 503A pharmacies for home delivery.

References

  1. 1.Ferreira G, Silva M, et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. American Journal of Physiology-Endocrinology and Metabolism. 2023.
  2. 2.Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021.
  3. 3.Bogan KL, Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annual Review of Nutrition. 2008.
  4. 4.Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018.
  5. 5.Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021.
  6. 6.ClinicalTrials.gov. The Effects of Nicotinamide Adenine Dinucleotide on Brain Function and Cognition, NCT02942888. 2016.
  7. 7.Hoffman KL, et al. Intravenous infusion of nicotinamide adenine dinucleotide and nicotinamide riboside in a commercial setting: tolerability, safety markers, and metabolic outcomes. Frontiers in Aging. 2026.
  8. 8.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. 2025.
  9. 9.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 2024.

About this article

Chia Health Editorial TeamEvidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

See if semaglutide is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides